We offer comprehensive non-clinical platforms for gene therapies and vaccines, including siRNA, mRNA, AAV, and oncolytic viruses. Our capabilities span specialized delivery routes—such as subretinal and brain stereotactic injections—and include non-human primate models for translational relevance. These systems support POC validation, challenge studies, pharmacodynamics, and safety evaluation, facilitating the development of next-generation biologics.
Assays Established and Validated for Vaccine Development under GLP
-
Test Item
Testing Method
-
Pseudovirus neutralizing antibody detection
In vitro cellular method
-
Detection of SARS-CoV-2 virus in samples (body fluids, tissues, swabs, etc.)
QPCR
-
Detection of anti S protein specific antibodies in serum of mice, rats, and monkeys
ELISA
-
Detection of specific antibodies against S-RBD protein in serum of mice, rats, and monkeys
ELISA
-
Detection of anti N protein specific antibodies in serum of mice, rats, and monkeys
ELISA
-
Detection of anti M protein specific antibodies in serum of mice, rats, and monkeys
ELISA
-
Determination of adenovirus content in serum of rats and monkeys
QPCR
-
Determination of vaccine mRNA content in serum of rats and monkeys
QPCR
-
IL-2, IL-4, IL-5, IL-6, IL-10, IFN-γ, TNF-a and other cytokines (microsamples)
MSD
-
IL-2, IL-4, IL-5, IL-6, IL-10, IFN-γ, TNF-a and other cytokines
CBA Flow Cytometry
-
CD3, CD4, CD8 and other T cell phenotypes
Flow Cytometry
-
Immunoglobulin IgG, IgM, IgA, IgE
ELISA or MSD
-
Taxonomy of blood and body fluid cells
Sysmex XN1000 Multifunctional Body Fluid Analyzer
-
Biochemistry (89 analytical items)
Hitachi 7180 Automatic Biochemistry Analyzer
-
Histopathology, immunohistochemistry
Team of professional veterinarians and pathologists
Research Projects
Accomplished
-
30 +
Conducted 30 gene therapy product evaluation projects
-
30 +
Supported more than 30 products to entry into the clinical III phase
-
Received the world's first clinical approval for a multi-targeted cellular therapy product for solid tumors